Ładuje się......
Predicting potential adverse events using safety data from marketed drugs
BACKGROUND: While clinical trials are considered the gold standard for detecting adverse events, often these trials are not sufficiently powered to detect difficult to observe adverse events. We developed a preliminary approach to predict 135 adverse events using post-market safety data from markete...
Zapisane w:
| Wydane w: | BMC Bioinformatics |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BioMed Central
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7191698/ https://ncbi.nlm.nih.gov/pubmed/32349656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-020-3509-7 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|